Suzhou Municipal Hospital
🇨🇳China
A Technique Improves Urinary Continence in Patients Undergoing Laparoscopic Radical Prostatectomy
Not Applicable
Recruiting
- Conditions
- Posterior Bladder Wall ReconstructionAnterior Bladder Wall ReconstructionAnterior Bladder Wall Suspension
- First Posted Date
- 2024-12-31
- Last Posted Date
- 2024-12-31
- Lead Sponsor
- Suzhou Municipal Hospital
- Target Recruit Count
- 120
- Registration Number
- NCT06754488
- Locations
- 🇨🇳
Suzhou Municipal Hospital, Suzhou, Jiangsu, China
Safety and Efficacy Study of NGGT006 in Refractory Hypercholesterolemia Patients
Early Phase 1
Not yet recruiting
- Conditions
- Familial HypercholesterolemiaRefractory Hypercholesterolemia
- Interventions
- Drug: NGGT006
- First Posted Date
- 2024-03-05
- Last Posted Date
- 2024-04-17
- Lead Sponsor
- Suzhou Municipal Hospital
- Target Recruit Count
- 9
- Registration Number
- NCT06293729
Focused Power Ultrasound Mediated Inferior Perirenal Adipose Tissue Modification Therapy for Essential Hypertension (PARADISE HTN-III)
Not Applicable
Recruiting
- Conditions
- HypertensionBlood PressureCardiovascular Diseases
- Interventions
- Device: focused power ultrasound mediate inferior perirenal adipose tissue modificationDevice: Sham-control group
- First Posted Date
- 2024-02-28
- Last Posted Date
- 2024-06-04
- Lead Sponsor
- Suzhou Municipal Hospital
- Target Recruit Count
- 30
- Registration Number
- NCT06283758
- Locations
- 🇨🇳
The Affiliated Jiangning Hospital of Nanjing Medical University, Nanjing, Jiangsu, China
🇨🇳Affiliated Hospital of Nantong University, Nantong, Jiangsu, China
🇨🇳The first Affiliated Hospital of Nanjing Medical University, Nanjing, Jiangsu, China
The Effect of LIPUS on the Maturation of Newly Constructed Autogenous AVF
Not Applicable
Recruiting
- Conditions
- Uremia; Chronic
- Interventions
- Device: Low intensity pulse ultrasound （LIPUS） intervention for arteriovenous fistula anastomosis
- First Posted Date
- 2024-02-08
- Last Posted Date
- 2024-05-16
- Lead Sponsor
- Suzhou Municipal Hospital
- Target Recruit Count
- 300
- Registration Number
- NCT06249373
- Locations
- 🇨🇳
The Affiliated Suzhou Hospital of Nanjing Medical University, Suzhou Municipal Hospital, Suzhou, Jiangsu, China
Optimization of Postoperative Adjuvant Therapy for Cervical Cancer Based on MRD(Minimal Residual Disease)
Phase 2
Recruiting
- Conditions
- Cervical Cancer
- Interventions
- Drug: Chemoradiotherapy (small pelvic) + ZimberelimabDrug: Chemoradiotherapy + Adjuvant chemotherapy and Zimberelimab
- First Posted Date
- 2023-05-24
- Last Posted Date
- 2023-05-24
- Lead Sponsor
- Suzhou Municipal Hospital
- Target Recruit Count
- 32
- Registration Number
- NCT05872724
- Locations
- 🇨🇳
The Affiliated Suzhou Hospital of Nanjing Medical University, Suzhou, Jiangsu, China
Senile Osteoporotic Fractures Cohort Study（SOFCS）
Recruiting
- Conditions
- Osteoporotic Fractures
- First Posted Date
- 2023-05-08
- Last Posted Date
- 2023-11-22
- Lead Sponsor
- Suzhou Municipal Hospital
- Target Recruit Count
- 2000
- Registration Number
- NCT05848167
- Locations
- 🇨🇳
Suzhou Municipal Hospital, Suzhou, Jiangsu, China
Efficacy and Safety Analysis of ICIs Plus Angiogenesis Inhibitors for Treatment of Advanced NSCLC in Elderly Patients
Completed
- Conditions
- NSCLC
- Interventions
- Drug: Immune checkpoint inhibitors plus angiogenesis inhibitorsDrug: Immune checkpoint inhibitors without angiogenesis inhibitors
- First Posted Date
- 2023-01-18
- Last Posted Date
- 2023-01-19
- Lead Sponsor
- Suzhou Municipal Hospital
- Target Recruit Count
- 79
- Registration Number
- NCT05688046
- Locations
- 🇨🇳
The Affiliated Suzhou Hospital of Nanjing Medical University, Suzhou, Jiangsu, China
Bicuspid Echocardiac Study Team（BEST）
Recruiting
- Conditions
- Bicuspid Aortic Valve Disease
- First Posted Date
- 2022-12-19
- Last Posted Date
- 2023-11-22
- Lead Sponsor
- Suzhou Municipal Hospital
- Target Recruit Count
- 200
- Registration Number
- NCT05656820
- Locations
- 🇨🇳
Suzhou Municipal Hospital, Suzhou, China
TACE Combined With Methylcantharidimide Tablets in the Treatment of Large and Unresectable Hepatocellular Carcinoma
Phase 4
- Conditions
- Hepatocellular Carcinoma
- Interventions
- Drug: methylcantharidimide tablets
- First Posted Date
- 2019-06-25
- Last Posted Date
- 2019-06-25
- Lead Sponsor
- Suzhou Municipal Hospital
- Target Recruit Count
- 22
- Registration Number
- NCT03996681
- Locations
- 🇨🇳
Suzhou Municipal Hospital, Suzhou, Jiangsu, China
© Copyright 2025. All Rights Reserved by MedPath